Doxycycline for Injection 100mg/vial — a sterile broad-spectrum tetracycline antibiotic for intravenous infusion when oral therapy is not fe
Doxycycline for Injection 100mg/vial — a sterile broad-spectrum tetracycline antibiotic for intravenous infusion when oral therapy is not feasible, used for severe respiratory, skin and systemic infections and severe malaria adjunct. GMP sterile manufactured by Artemisine Medicines Technology with COA/DMF/CTD dossier support for global export.
| Product Name | Doxycycline for Injection 100mg |
|---|---|
| Dosage Form | Powder for Injection |
| Strength | 100 mg / vial |
| Standards | BP / ENTERPRISE |
| Packing | 10 vials per box |
| Documents | COA, COPP, DMF, CTD Dossiers |
| MOQ | Contact us for MOQ and current stock |
Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.
Reference: WHO Model List of Essential Medicines / WHO Model Formulary. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.
Full batch testing and quality traceability under standard GMP workshops.
Sufficient stock on regular items, familiar with export logistics to 50+ countries.
COA, DMF, dossier and legalization documents for your market registration.
Every batch of Doxycycline for Injection 100mg ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.
MOQ and lead time for Doxycycline for Injection 100mg depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.
Yes. We offer OEM packaging and private-label production for Doxycycline for Injection 100mg, subject to the regulatory requirements of the destination market.
We have supplied injection products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.
Doxycycline for Injection 100mg is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.